Valuation: Zenotech Laboratories Limited

Market Cap 2.75B 28.73M 25.09M 23.57M 21.53M 40.41M 40.39M 283M 109M 1.4B 108M 106M 4.52B P/E 2025
56.5x
P/E 2026 -191x
Enterprise Value 2.44B 25.55M 22.31M 20.96M 19.15M 35.93M 35.91M 251M 96.94M 1.25B 95.95M 93.84M 4.02B EV / Sales 2025
7.42x
EV / Sales 2026 4.45x
Free-Float
15.47%
Yield 2025 *
-
Yield 2026 -
07-28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
04-29 Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
01-23 Zenotech Laboratories Limited Announces Cessation of Chintan Jitendra Shah as Independent Director, Chairman of the Nomination and Remuneration Committee, Member of Audit Committee/ Stakeholders Relationship Committee and Reconstitution of Board Committees CI
01-23 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
25-10-31 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-25 Zenotech Laboratories Limited Announces Updation of Address of the Registered Office CI
25-07-28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-03-30 Zenotech Laboratories Limited Announces Cessation of Kavita Rakesh Shah as Independent Director, with Effect from April 01, 2025 CI
25-01-28 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
24-10-23 Zenotech Laboratories Limited Appoints Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) CI
24-10-23 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
24-07-26 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
24-05-17 Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024 CI
1 day+0.36%
1 week+0.04%
Current month-2.70%
1 month-2.70%
3 months+1.47%
6 months+12.50%
Current year-2.58%
1 week 43.85
Extreme 43.85
46
1 month 43.45
Extreme 43.45
50
Current year 33.55
Extreme 33.55
50.93
1 year 33.55
Extreme 33.55
54.5
3 years 33.55
Extreme 33.55
107.79
5 years 33.55
Extreme 33.55
107.79
10 years 12
Extreme 12
107.79
Manager TitleAgeSince
Chief Executive Officer - 2024-10-22
Director of Finance/CFO - 2014-02-05
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member 58 2015-07-07
Chairman 67 -
Director/Board Member 53 2020-01-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.36%+0.04%-14.35%-18.57% 28.57M
+0.45%+2.80%+55.61%+112.70% 1,038B
-0.10%+1.08%+52.78%+66.52% 649B
+0.28%+1.31%+19.21%+72.85% 467B
-0.19%+0.75%+37.34%+45.03% 355B
+0.28%+2.23%+19.12%+25.62% 269B
+0.89%+4.26%+12.10%+16.41% 260B
+4.34%+7.53%+43.74%+52.27% 213B
-0.46%-7.70%-33.40%-59.71% 176B
+1.40%+4.28%+33.82%+102.83% 187B
Average +0.55%+0.91%+22.60%+41.60% 361.51B
Weighted average by Cap. +0.50%+1.47%+36.59%+66.72%

Financials

2025 2026
Net sales 391M 4.09M 3.57M 3.36M 3.07M 5.75M 5.75M 40.22M 15.52M 200M 15.36M 15.02M 644M 402M 4.2M 3.67M 3.45M 3.15M 5.91M 5.91M 41.31M 15.94M 205M 15.78M 15.43M 661M
Net income 56.13M 587K 513K 482K 440K 826K 825K 5.77M 2.23M 28.66M 2.21M 2.16M 92.43M -10.72M -112K -97.94K -92.02K -84.06K -158K -158K -1.1M -426K -5.48M -421K -412K -17.65M
Net Debt -267M -2.79M -2.44M -2.29M -2.09M -3.93M -3.93M -27.47M -10.6M -136M -10.49M -10.26M -440M -304M -3.18M -2.78M -2.61M -2.39M -4.48M -4.47M -31.3M -12.08M -155M -11.95M -11.69M -501M
Logo Zenotech Laboratories Limited
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. Its product includes granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
Employees
264
Date Price Change Volume
26-09-22 ₹45.00 +0.36% 8,503
26-09-21 ₹44.84 +1.36% 3,221
26-09-18 ₹44.24 -1.69% 1,334
26-09-17 ₹45.00 +1.47% 3,559
26-09-16 ₹44.35 +0.20% 3,976
  1. Stock Market
  2. Stocks
  3. ZENOTECH6 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!